Chlorpheniramine maleate and Thrombocytopenia - a phase IV clinical study of FDA data
Thrombocytopenia is found among people who take Chlorpheniramine maleate, especially for people who are male, 60+ old, have been taking the drug for < 1 month.
The phase IV clinical study analyzes which people take Chlorpheniramine maleate and have Thrombocytopenia. It is created by eHealthMe based on reports of 3,789 people who have side effects when taking Chlorpheniramine maleate from the FDA, and is updated regularly. You can use the study as a second opinion to make health care decisions.
With medical big data and AI algorithms, eHealthMe enables everyone to run phase IV clinical trial to detect adverse drug outcomes and monitor effectiveness. Our original studies have been referenced on 600+ peer-reviewed medical publications including The Lancet, Mayo Clinic Proceedings, and Nature. Most recently, phase IV clinial trails for COVID 19 vaccines have been added, check here.
3,789 people reported to have side effects when taking Chlorpheniramine maleate.
Among them, 171 people (4.51%) have Thrombocytopenia.
What is Chlorpheniramine maleate?
Chlorpheniramine maleate has active ingredients of chlorpheniramine maleate. It is often used in allergies. eHealthMe is studying from 4,127 Chlorpheniramine maleate users for its effectiveness, alternative drugs and more.
What is Thrombocytopenia?
Thrombocytopenia (decrease of platelets in blood) is found to be associated with 3,689 drugs and 4,279 conditions by eHealthMe.
Number of Chlorpheniramine maleate and Thrombocytopenia reports submitted per year:
Time on Chlorpheniramine maleate when people have Thrombocytopenia *:
Gender of people who have Thrombocytopenia when taking Chlorpheniramine maleate*:
Age of people who have Thrombocytopenia when taking Chlorpheniramine maleate *:
Common drugs people take besides Chlorpheniramine maleate *:
Common side effects people have besides Thrombocytopenia *:
Common conditions people have *:
* Approximation only. Some reports may have incomplete information.
Do you take Chlorpheniramine maleate and have Thrombocytopenia?Check whether Thrombocytopenia is associated with a drug or a condition
How to use the study?
You can discuss the study with your doctor, to ensure that all drug risks and benefits are fully discussed and understood.
Related publications that referenced our studies
- YavasogluI, I., TurgutkayaII, A., & BolamanIII, Z., "Chlorella-induced thrombocytopenia", DATA, 2018 Jan .
- Rasmy A, Rahal M, Kisana M, Ahmad S, Salah A, "Morphine induced thrombocytopenia: A case report", Journal of Case Reports and Images in Oncology, 2015 Dec .
- Onder H, Arsava EM, Arat A, Topcuoglu MA, "Acute middle cerebral artery occlusion treated by thrombectomy in a patient with myelodysplastic syndrome and severe thrombocytopenia", Journal of vascular and interventional neurology, 2015 Jan .
Alternative drugs to, pros and cons of Chlorpheniramine maleate:
- Chlorpheniramine maleate (4,127 reports)
Thrombocytopenia treatments and more:
- Thrombocytopenia (226,205 reports)
COVID vaccines that are related to Thrombocytopenia:
- Thrombocytopenia in Moderna COVID Vaccine
- Thrombocytopenia in Pfizer BioNTech Covid Vaccine
- Thrombocytopenia in Johnson and Johnson Covid Vaccine
How severe was Thrombocytopenia and when was it recovered:
Expand to all the drugs that have ingredients of chlorpheniramine maleate:
Common drugs associated with Thrombocytopenia:
All the drugs that are associated with Thrombocytopenia:
- Thrombocytopenia (3,689 drugs)
Common conditions associated with Thrombocytopenia:
All the conditions that are associated with Thrombocytopenia:
- Thrombocytopenia (4,279 conditions)
How the study uses the data?
The study uses data from the FDA. It is based on chlorpheniramine maleate (the active ingredients of Chlorpheniramine maleate) and Chlorpheniramine maleate (the brand name). Other drugs that have the same active ingredients (e.g. generic drugs) are not considered. Dosage of drugs is not considered in the study.
Who is eHealthMe?
With medical big data and proven AI algorithms, eHealthMe provides a platform for everyone to run phase IV clinical trials. We study millions of patients and 5,000 more each day. Results of our real-world drug study have been referenced on 600+ peer-reviewed medical publications, including The Lancet, Mayo Clinic Proceedings, and Nature. Our analysis results are available to researchers, health care professionals, patients (testimonials), and software developers (open API).
WARNING, DISCLAIMER, USE FOR PUBLICATION
WARNING: Please DO NOT STOP MEDICATIONS without first consulting a physician since doing so could be hazardous to your health.
DISCLAIMER: All material available on eHealthMe.com is for informational purposes only, and is not a substitute for medical advice, diagnosis, or treatment provided by a qualified healthcare provider. All information is observation-only. Our phase IV clinical studies alone cannot establish cause-effect relationship. Different individuals may respond to medication in different ways. Every effort has been made to ensure that all information is accurate, up-to-date, and complete, but no guarantee is made to that effect. The use of the eHealthMe site and its content is at your own risk.
If you use this eHealthMe study on publication, please acknowledge it with a citation: study title, URL, accessed date.
Recent studies on eHealthMe:
- Escitalopram Oxalate and Gastrointestinal Infection - now
- Zenatane vs. Clindamycin Phosphate - 2 seconds ago
- Herceptin and Facial Pain - 16 seconds ago
- Duragesic and Systemic Sclerosis (Scleroderma) - 16 seconds ago
- Xolair and Kenalog drug interaction - 16 seconds ago